CEBPA gene homepage

General information
Gene symbol CEBPA
Gene name CCAAT enhancer binding protein alpha
Chromosome 19
Chromosomal band q13.11
Imprinted Unknown
Genomic reference LRG_456
Transcript reference NM_004364.3
Associated with diseases AML
Citation reference(s) -
Curators (1) Despoina Kalfakakou
Total number of public variants reported 36
Unique public DNA variants reported 15
Individuals with public variants 37
Hidden variants 0
Date created May 20, 2020
Date last updated May 20, 2020
Version CEBPA:200520

Graphical displays and utilities
Graphs Graphs displaying summary information of all variants in the database »
UCSC Genome Browser Show variants in the UCSC Genome Browser (full view, compact view)
Ensembl Genome Browser Show variants in the Ensembl Genome Browser (full view, compact view)
NCBI Sequence Viewer Show distribution histogram of variants in the NCBI Sequence Viewer

Links to other resources
HGNC 1833
Entrez Gene 1050
PubMed articles CEBPA
OMIM - Gene 116897
OMIM - Diseases AML (Acute Myeloid Leukemia)


Active transcripts


ID     

Chr     

Name     

NCBI ID     

NCBI Protein ID     

DescendingVariants     
00000031 19 CCAAT/enhancer binding protein (C/EBP), alpha NM_004364.3 NP_004355.2 36


Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2020. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.